Literature DB >> 33442401

Comparison of clinicopathological parameters, prognosis, micro-ecological environment and metabolic function of Gastric Cancer with or without Fusobacterium sp. Infection.

Siru Nie1,2,3, Ang Wang1,2,3, Yuan Yuan1,2,3.   

Abstract

Background: Fusobacterium sp. plays a crucial role in the tumorigenesis and development of gastrointestinal tumors. Our research group previously disclosed that Fusobacterium sp. was more abundant in gastric cancer (GC) tissues than adjacent non-cancerous (NC) tissues. However, Fusobacterium sp. did not exist in all GC tissues and the differentiated features of GC with or without Fusobacterium sp. infection is not clear.
Methods: The expression data of 61 GC tissues came from 16S rRNA gene sequencing. Comparison groups were defined based on sOTU at the genus level of Fusobacterium sp., which was performed by the Qiime2 microbiome bioinformatics platform. We used Chi-square and Fisher's exact test to compare clinicopathological parameters, and used Kaplan-Meier analysis, Cox univariate and multivariate analysis to compare prognosis. Micro-ecological environment comparison was characterized by 16S rRNA gene sequencing, and the metabolic function prediction was applied by PICRUSt2. Results of microbial diversity, differential enrichment genus and metabolic function in GC with or without Fusobacterium sp. infection was validated with 229 GC tissues downloaded from an independent cohort in ENA database (PRJNA428883).
Results: The infection rate of Fusobacterium sp. in 61 GC tissues was 52.46% and elderly GC patients were more prone to Fusobacterium sp. infection. GC patients infected with Fusobacterium sp. were more likely to have tumor-infiltrating lymphocytes and p53 expression. The microbial diversity and microbial structure showed significant differences between two GC tissue groups with 42 differential enrichment genera. The metabolic function of Fusobacterium sp.-positive GC tissues was related to the biosynthesis of lysine, peptidoglycan, and tRNA. The differences in microbial structure, the existence of some differential enrichment genera and the metabolic function of Fusobacterium sp.-positive GC tissues, were then validated by 229 GC tissues of an independent cohort. Conclusions: Fusobacterium sp. infection can affect the phenotypic characteristics, micro-ecological environment, and metabolic functions of GC, which may provide a basis for further exploring the relationship between Fusobacterium sp. infection and carcinogenesis of GC. © The author(s).

Entities:  

Keywords:  16S rRNA; Fusobacterium sp.; clinicopathological feature; gastric cancer; metabolic function; micro-ecological environment

Year:  2021        PMID: 33442401      PMCID: PMC7797643          DOI: 10.7150/jca.50918

Source DB:  PubMed          Journal:  J Cancer        ISSN: 1837-9664            Impact factor:   4.207


  42 in total

1.  Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin.

Authors:  Mara Roxana Rubinstein; Xiaowei Wang; Wendy Liu; Yujun Hao; Guifang Cai; Yiping W Han
Journal:  Cell Host Microbe       Date:  2013-08-14       Impact factor: 21.023

2.  Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.

Authors:  Kosuke Mima; Yasutaka Sukawa; Reiko Nishihara; Zhi Rong Qian; Mai Yamauchi; Kentaro Inamura; Sun A Kim; Atsuhiro Masuda; Jonathan A Nowak; Katsuhiko Nosho; Aleksandar D Kostic; Marios Giannakis; Hideo Watanabe; Susan Bullman; Danny A Milner; Curtis C Harris; Edward Giovannucci; Levi A Garraway; Gordon J Freeman; Glenn Dranoff; Andrew T Chan; Wendy S Garrett; Curtis Huttenhower; Charles S Fuchs; Shuji Ogino
Journal:  JAMA Oncol       Date:  2015-08       Impact factor: 31.777

3.  Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.

Authors:  Shuang Wei; Min Xiong; Da-qian Zhan; Bin-yong Liang; Yang-yang Wang; David H Gutmann; Zhi-yong Huang; Xiao-ping Chen
Journal:  Carcinogenesis       Date:  2012-01-05       Impact factor: 4.944

4.  16S-23S rDNA internal transcribed spacer sequences for analysis of the phylogenetic relationships among species of the genus Fusobacterium.

Authors:  Georg Conrads; Marina C Claros; Diane M Citron; Kerin L Tyrrell; Vreni Merriam; Ellie J C Goldstein
Journal:  Int J Syst Evol Microbiol       Date:  2002-03       Impact factor: 2.747

5.  Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients.

Authors:  Yu-Yuan Li; Quan-Xing Ge; Jie Cao; Yong-Jian Zhou; Yan-Lei Du; Bo Shen; Yu-Jui Yvonne Wan; Yu-Qiang Nie
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

6.  Mucosa-Associated Microbiota in Gastric Cancer Tissues Compared With Non-cancer Tissues.

Authors:  Xiao-Hui Chen; Ang Wang; Ai-Ning Chu; Yue-Hua Gong; Yuan Yuan
Journal:  Front Microbiol       Date:  2019-06-05       Impact factor: 5.640

7.  Fusobacterium nucleatum Caused DNA Damage and Promoted Cell Proliferation by the Ku70/p53 Pathway in Oral Cancer Cells.

Authors:  Fengxue Geng; Yunjia Zhang; Ze Lu; Shuwei Zhang; Yaping Pan
Journal:  DNA Cell Biol       Date:  2019-11-25       Impact factor: 3.311

8.  Fusobacterium nucleatum in gastroenterological cancer: Evaluation of measurement methods using quantitative polymerase chain reaction and a literature review.

Authors:  Kensuke Yamamura; Yoshifumi Baba; Keisuke Miyake; Kenichi Nakamura; Hironobu Shigaki; Kosuke Mima; Junji Kurashige; Takatsugu Ishimoto; Masaaki Iwatsuki; Yasuo Sakamoto; Yoichi Yamashita; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  Oncol Lett       Date:  2017-09-19       Impact factor: 2.967

9.  Mucosal microbiome dysbiosis in gastric carcinogenesis.

Authors:  Olabisi Oluwabukola Coker; Zhenwei Dai; Yongzhan Nie; Guijun Zhao; Lei Cao; Geicho Nakatsu; William Kk Wu; Sunny Hei Wong; Zigui Chen; Joseph J Y Sung; Jun Yu
Journal:  Gut       Date:  2017-08-01       Impact factor: 23.059

10.  Changes of the Gastric Mucosal Microbiome Associated With Histological Stages of Gastric Carcinogenesis.

Authors:  Zikai Wang; Xuefeng Gao; Ranran Zeng; Qiong Wu; Huaibo Sun; Wenming Wu; Xiaomei Zhang; Gang Sun; Bin Yan; Lili Wu; Rongrong Ren; Mingzhou Guo; Lihua Peng; Yunsheng Yang
Journal:  Front Microbiol       Date:  2020-05-29       Impact factor: 5.640

View more
  4 in total

1.  A Novel Microbiome Signature in Gastric Cancer: A Two Independent Cohort Retrospective Analysis.

Authors:  Miseker Abate; Elvira Vos; Mithat Gonen; Yelena Y Janjigian; Mark Schattner; Monika Laszkowska; Laura Tang; Steven B Maron; Daniel G Coit; Santosh Vardhana; Chad Vanderbilt; Vivian E Strong
Journal:  Ann Surg       Date:  2022-07-13       Impact factor: 13.787

Review 2.  Role of the Gastric Microbiome in Gastric Cancer: From Carcinogenesis to Treatment.

Authors:  Jinpu Yang; Xinxin Zhou; Xiaosun Liu; Zongxin Ling; Feng Ji
Journal:  Front Microbiol       Date:  2021-03-15       Impact factor: 5.640

Review 3.  Host miRNAs-microbiota interactions in gastric cancer.

Authors:  Yan Yang; Yingying Huang; Wu Lin; Jin Liu; Xiangliu Chen; Chuanzhi Chen; Xiongfei Yu; Lisong Teng
Journal:  J Transl Med       Date:  2022-01-29       Impact factor: 5.531

Review 4.  Relationships among microbiota, gastric cancer, and immunotherapy.

Authors:  Yuzhen Li; Xiaona Huang; Desheng Tong; Chenyu Jiang; Xiaodan Zhu; Zhipeng Wei; Tingjie Gong; Chunhui Jin
Journal:  Front Microbiol       Date:  2022-09-12       Impact factor: 6.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.